#CLVT

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

2 weeks ago

#CLVT #^GSPC #^IXIC #54dbae19-c059-4001-9cad-422ae13b0bdb #investing #Technology #and #Telecom

Origin | Interest | Match

StockTitan

@stocktitan.net

1 month ago

Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources Clarivate (NYSE: CLVT) announced Clarivate Nexus, an academic assistant that embeds library content and services into AI tools, web environments, and campus systems to reconnect students and researchers with trusted scholarly resources.Core features include unified library access, full-text linking from AI outputs, source verification and citation support, literature recommendations, and surfaced library services. Nexus will launch as a browser extension with a planned early access release in Q3 2026 and later support direct campus integrations. The product emphasizes entitlement-aware access, user privacy, and library branding, and is built on Clarivate indexes including Web of Science and ProQuest collections.

#CLVT Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources

www.stocktitan.net/news/CLVT/clarivate-intr...

StockTitan

@stocktitan.net

2 months ago

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report Clarivate (NYSE: CLVT) released its Drugs to Watch 2026 report on January 6, 2026, identifying eleven therapies that may reach blockbuster status or transform care within five years (blockbuster defined as ≥USD 1 billion annual sales).The report covers advances across metabolic disease, oncology, immunology, rare conditions and protein degraders, cites over 160 analysts reviewing hundreds of drugs using ten AI-enhanced datasets, and highlights delivery innovation and Mainland China as a growing commercial and innovation force.

#CLVT Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

www.stocktitan.net/news/CLVT/clarivate-iden...

StockTitan

@stocktitan.net

3 months ago

Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance Clarivate (NYSE:CLVT) on December 4, 2025 launched the Cortellis Regulatory Intelligence AI Assistant, an agentic AI tool now available to all Cortellis Regulatory Intelligence customers.The assistant provides instant, cited, context-aware answers; multilingual support; rapid document summarization; and draft-versus-final guidance comparison to speed regulatory review and decision making. Developed with customer feedback and built on Clarivate's existing AI platform, the product targets life sciences regulatory teams and aims to improve accuracy and workflow efficiency across the product lifecycle.

#CLVT Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

www.stocktitan.net/news/CLVT/clarivate-pres...

StockTitan

@stocktitan.net

3 months ago

Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI Clarivate (NYSE: CLVT) launched Derwent Patent Monitor on November 24, 2025 to streamline IP and R&D patent reviews and accelerate decisions on patentability, freedom to operate (FTO), opposition and assertion.The cloud solution uses AI-powered threat analysis built on proprietary Derwent World Patents Index data — including 67m+ invention summaries authored by 850+ Clarivate experts — to surface critical risks and speed first-pass reviews. The product is purpose-built for collaboration with structured project reviews and real-time feedback to reduce reliance on scattered emails and spreadsheets and help patent teams align more quickly.

#CLVT Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI

www.stocktitan.net/news/CLVT/clarivate-laun...

StockTitan

@stocktitan.net

4 months ago

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health. LONDON, Nov. 13, 2025/ PRNewswire/-- Clarivate Plc, a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Women's Health, highlighting seven...

#CLVT Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care

www.stocktitan.net/news/CLVT/clarivate-comp...

StockTitan

@stocktitan.net

4 months ago

Clarivate Announces Highly Cited Researchers 2025 List Clarivate (NYSE:CLVT) released the Highly Cited Researchers 2025 list on November 12, 2025, recognizing 6,868 individuals with 7,131 awards from 1,300+ institutions in 60 countries.Key metrics: the U.S. leads with 2,670 awards (37%); Mainland China second with 1,406 awards (20%); Chinese Academy of Sciences tops institutions with 258 awards. The program added scrutiny in 2025 and excluded 432 potential awards for hyper-prolific publication; Mathematics was reintroduced.

#CLVT Clarivate Announces Highly Cited Researchers 2025 List

www.stocktitan.net/news/CLVT/clarivate-anno...

StockTitan

@stocktitan.net

7 months ago

2,700+ Libraries Worldwide: Clarivate Expands Alma Platform with University of Melbourne Partnership Clarivate to provide Alma, Primo, Leganto, Rapido and Library Open Workflows solutions to Australia's leading university, enhancing research access and AI-driven operations.

#CLVT Clarivate Partners with the University of Melbourne to Transform Library Systems

www.stocktitan.net/news/CLVT/clarivate-part...

Being Exponential | Luke Lango

@beingexponential.bsky.social

7 months ago

-#CLVT said that AI agents are now capable of independently executing multi-step processes by interacting with users, data sources, and tools
-#FVRR said demand is surging for AI agents

StockTitan

@stocktitan.net

7 months ago

Clarivate Announces Maroun S. Mourad as President, Intellectual Property Clarivate (NYSE:CLVT) has appointed Maroun S. Mourad as President of its Intellectual Property segment, effective September 8, 2025. Mourad, who previously served as President of Claims Solutions at Verisk Analytics, succeeds Gordon Samson, who will retire at the end of 2025.Mourad brings extensive experience in data analytics and software, having grown businesses across the U.S., U.K., Europe, and emerging markets since 1998. He holds a BA in political science and a JD from UC Berkeley. The appointment aligns with Clarivate's strategy to drive long-term predictable growth in its IP business, which provides IP data, software, and expertise for innovation management and IP asset protection.

#CLVT Clarivate Announces Maroun S. Mourad as President, Intellectual Property

www.stocktitan.net/news/CLVT/clarivate-anno...

StockTitan

@stocktitan.net

7 months ago

Clarivate Q2 2025 Shows Business Transformation Success: Recurring Revenue Jumps 800 Basis Points Clarivate delivers 0.5% organic growth and 88% recurring revenue mix in Q2. Management reaffirms 2025 outlook amid transformation. See full performance metrics.

#CLVT Clarivate Reports Second Quarter 2025 Results

www.stocktitan.net/news/CLVT/clarivate-repo...

StockTitan

@stocktitan.net

8 months ago

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology Clarivate (NYSE:CLVT) has released a new Companies to Watch report focused on radioligand therapy (RLT) innovators in precision oncology. The report highlights six emerging companies: Affibody, Alpha-9 Oncology, Ariceum Therapeutics, Convergent Therapeutics, Perspective Therapeutics, and PRECIRIX, who are advancing next-generation radiopharmaceuticals. RLTs combine nuclear medicine with targeted biotechnology to deliver radioactive isotopes directly to tumor cells while minimizing damage to healthy tissue. The report examines scientific breakthroughs, strategic investments, M&A activity, and market trends, noting significant acquisitions like Bristol Myers Squibb's $4.1B purchase of RayzeBio and AstraZeneca's $2.4B acquisition of Fusion Pharmaceuticals. The global radiopharmaceutical market is projected to exceed $13B in the next decade, with successful therapies like Novartis' PLUVICTO and LUTATHERA leading adoption.

#CLVT Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

www.stocktitan.net/news/CLVT/clarivate-iden...

StockTitan

@stocktitan.net

9 months ago

Clarivate Expands Web of Science Access to 55 Canadian Universities in Major Research Partnership New partnership grants Canadian universities expanded access to Web of Science API, Derwent Index, and research tools through 2029. See how this transforms research capabilities.

#CLVT Clarivate Partners with CRKN to Further Canada's Research Goals

www.stocktitan.net/news/CLVT/clarivate-part...

StockTitan

@stocktitan.net

9 months ago

Clarivate Successfully Refinances $500M Debt: New Deal Cuts Interest Costs and Extends Maturity Just completed: Clarivate restructures major debt portion with improved terms. New $500M term loan extends maturity to 2031, enhancing financial flexibility. See full details.

#CLVT Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026

www.stocktitan.net/news/CLVT/clarivate-comp...

StockTitan

@stocktitan.net

9 months ago

AI Breakthrough: Clarivate RiskMark Transforms Trademark Risk Assessment with 172M-Record Database New AI solution combines CompuMark and Darts-ip data to revolutionize trademark conflict assessment. Discover how RiskMark accelerates decision-making. See features.

#CLVT Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments

www.stocktitan.net/news/CLVT/clarivate-laun...

StockTitan

@stocktitan.net

10 months ago

Clarivate Reports First Quarter 2025 Results Net loss for the first quarter of 2025 was $103.9 million, or $0.15 per diluted share, compared to a net loss of $75.0 million, or $0.14 per diluted share, for the first quarter of 2024. Adjusted net income for the first quarter of 2025 was $95.8 million, or $0.14 per diluted share, compared to $103.5 million, or $0.14 per diluted share, for the first quarter of 2024.

#CLVT Clarivate Reports First Quarter 2025 Results

www.stocktitan.net/news/CLVT/clarivate-repo...

StockTitan

@stocktitan.net

10 months ago

EndNote 2025 Revolutionizes Research Management with Advanced AI Features and Web of Science Integration Discover how EndNote's new AI-powered tools extract research insights, match journals, and streamline citations. Enhanced Web of Science integration coming. Learn more.

#CLVT Clarivate Releases EndNote 2025 with AI-Powered Research Tools

www.stocktitan.net/news/CLVT/clarivate-rele...

StockTitan

@stocktitan.net

11 months ago

Revolutionary AI Agents: How Clarivate is Transforming Academic Research New AI Agents platform enhances research workflows with Literature Review tools and customizable solutions. Already trusted by 3000+ institutions. Full rollout begins April 2025.

#CLVT Clarivate Expands its Academic AI Platform, Introducing Agentic AI for Research and Learning

www.stocktitan.net/news/CLVT/clarivate-expa...

StockTitan

@stocktitan.net

11 months ago

Clarivate's Game-Changing AI Partnership Transforms Patent Creation Process Clarivate integrates Iprova's AI invention platform with IPfolio, while acquiring Rowan Patents to create an end-to-end IP management ecosystem powered by artificial intelligence.

#CLVT Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process

www.stocktitan.net/news/CLVT/clarivate-part...

StockTitan

@stocktitan.net

1 year ago

Can Latin America's $98B Pharmaceutical Market Solve Import Dependency? Clarivate Study Uncovers Key Growth Strategies New Clarivate analysis identifies strategic partnerships, local API production, and regulatory modernization as critical drivers for pharmaceutical expansion in Latin America.

#CLVT Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

www.stocktitan.net/news/CLVT/clarivate-repo...

StockTitan

@stocktitan.net

1 year ago

Can Clarivate's New $500M Buyback and Strategic Review Offset Declining Revenues? Mixed Q4 results as Clarivate initiates strategic review and new buyback program while navigating revenue challenges. Net loss improves significantly year-over-year.

#CLVT Clarivate Reports Fourth Quarter and Full Year 2024 Results

www.stocktitan.net/news/CLVT/clarivate-repo...

StockTitan

@stocktitan.net

1 year ago

Academic Publishing Giant Revolutionizes Digital Access: 700K+ Ebooks Meet AI-Powered Research Clarivate unveils comprehensive subscription model offering 700K+ ebooks and 160M primary sources, featuring AI research tools and new mobile reader app.

#CLVT Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia

www.stocktitan.net/news/CLVT/clarivate-unve...

StockTitan

@stocktitan.net

1 year ago

National Library Revolution: Clarivate to Power 91 Croatian Institutions in Historic Digital Transformation Clarivate secures landmark deal to implement Ex Libris solutions across Croatia's academic network, transforming 91 institutions through cloud-based library services platform.

#CLVT Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform

www.stocktitan.net/news/CLVT/clarivate-sele...

StockTitan

@stocktitan.net

1 year ago

Revolutionary Heart Treatment Market Poised for 2600% Growth as PFA Technology Transforms Cardiac Care New Clarivate report reveals dramatic expansion in pulsed field ablation market, projecting 70% market share by 2028. Asia-Pacific emergence and technological advances drive unprecedented growth.

#CLVT Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

www.stocktitan.net/news/CLVT/clarivate-reve...

StockTitan

@stocktitan.net

1 year ago

World's Largest Library Transforms Operations with Groundbreaking Digital Platform British Library partners with Clarivate to implement Alma, Primo VE, and Rapido solutions, modernizing services for its 170M-item collection and enhancing research accessibility.

#CLVT The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

www.stocktitan.net/news/CLVT/the-british-li...

StockTitan

@stocktitan.net

1 year ago

BioWorld 2024 Review: Biopharma Rebounds Despite Industry Layoffs, GLP-1 Success Drives Growth Clarivate's annual report reveals biopharma financing recovery and GLP-1 expansion, while highlighting challenges from 18,000+ job cuts and Medicare coverage hurdles for new technologies.

#CLVT BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

www.stocktitan.net/news/CLVT/bio-world-by-c...

StockTitan

@stocktitan.net

1 year ago

Clarivate Launches DRG Fusion Platform to Transform Life Sciences Commercial Analytics Clarivate unveils integrated healthcare analytics platform combining medical and pharmacy claims data, with AI capabilities planned for 2025, to optimize biopharma commercial strategies.

#CLVT Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data

www.stocktitan.net/news/CLVT/clarivate-laun...

StockTitan

@stocktitan.net

1 year ago

Clarivate Reveals 11 Breakthrough Blockbuster Drugs Set to Transform Medicine by 2030 Clarivate's annual Drugs to Watch report spotlights groundbreaking therapies in obesity, oncology, and gene therapy, including the first weekly insulin and innovative disease treatments.

#CLVT Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

www.stocktitan.net/news/CLVT/clarivate-iden...

StockTitan

@stocktitan.net

1 year ago

Clarivate Unveils Massive $500M Share Buyback Program, Accelerates Debt Reduction Clarivate announces ambitious $500M share repurchase initiative for 2025-2026, following successful $300M buyback. Company strengthens balance sheet with $133M debt prepayment in 2024.

#CLVT Clarivate Announces New $500 Million Share Repurchase Authorization

www.stocktitan.net/news/CLVT/clarivate-anno...